Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -2024202320222021202020192018201720162015 31 March 2022 Biocartis Announces Publication of 2021 Annual Report Regulated information 24 February 2022 BIOCARTIS ANNOUNCES 2021 RESULTS AND 2022 OUTLOOK Regulated information 17 February 2022 BIOCARTIS ANNOUNCES 2021 FULL YEAR RESULTS ON 24 FEBRUARY 2022 Regulated information 8 February 2022 Biocartis and Ophiomics to Collaborate on Liver Cancer Test Non-regulated information 4 February 2022 Disclosure of a transparency notification Regulated information 25 January 2022 Large UK Study Shows Rapid EGFR Testing with Idylla™ Alongside NGS Has Potential to Enhance Lung Cancer Patient Health Outcomes Non-regulated information 10 January 2022 BIOCARTIS MEETS 2021 KEY OBJECTIVES Regulated information 9 December 2021 Biocartis’ Idylla™ SARS-CoV-2 testing Successfully Detects Omicron Variant Non-regulated information 30 November 2021 SeptiCyte® RAPID Receives 510(k) clearance by US FDA Non-regulated information 16 November 2021 New Study Demonstrates Idylla™ EGFR Mutation Test (CE-IVD) Shortens Time to Patient Management Decisions for Patients with Non-Small Cell Lung Cancer Non-regulated information Pagination First page « First Previous page ‹‹ … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page ›› Last page Last »